185 related articles for article (PubMed ID: 37892990)
1. The Impact of Clinical and Histopathological Factors on Disease Progression and Survival in Thick Cutaneous Melanomas.
Țăpoi DA; Derewicz D; Gheorghișan-Gălățeanu AA; Dumitru AV; Ciongariu AM; Costache M
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892990
[TBL] [Abstract][Full Text] [Related]
2. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.
Tas F; Erturk K
Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112
[TBL] [Abstract][Full Text] [Related]
3. Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma.
Tas F; Erturk K
Int J Dermatol; 2022 Apr; 61(4):472-479. PubMed ID: 34633070
[TBL] [Abstract][Full Text] [Related]
4. Neurotropism as a prognostic factor in cutaneous melanoma patients.
Tas F; Erturk K
Neoplasma; 2018; 65(2):304-308. PubMed ID: 29534593
[TBL] [Abstract][Full Text] [Related]
5. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
6. Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases.
Vița O; Jurescu A; Văduva A; Cornea R; Cornianu M; Tăban S; Szilagyi D; Micșescu C; Natarâș B; Dema A
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512052
[No Abstract] [Full Text] [Related]
7. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
8. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
9. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
10. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
Tas F; Erturk K
Am J Dermatopathol; 2022 Nov; 44(11):799-805. PubMed ID: 35925149
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
12. Digit melanomas are associated with poor prognostic factors and unfavorable survivals.
Tas F; Erturk K
J Cosmet Dermatol; 2022 May; 21(5):2120-2129. PubMed ID: 34333837
[TBL] [Abstract][Full Text] [Related]
13. Impact of clinical and histopathological characteristics on the disease-free survival of stage I-II acral melanoma patients.
Borges de Barros Primo R; Brito Nobre A; Santos BN; Nunes LF; Fernandes R; Abrão Possik P; Santos Bernardes S
Int J Dermatol; 2023 Oct; 62(10):1281-1288. PubMed ID: 37596798
[TBL] [Abstract][Full Text] [Related]
14. Seasonal variation in high-risk phenotypes of cutaneous malignant melanoma diagnosed in Eastern England: An observational study.
Sharp O; Garioch J; Moncrieff M
J Plast Reconstr Aesthet Surg; 2022 Jun; 75(6):1923-1930. PubMed ID: 35153165
[TBL] [Abstract][Full Text] [Related]
15. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
[TBL] [Abstract][Full Text] [Related]
16. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
[TBL] [Abstract][Full Text] [Related]
18. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
Nagarajan P; Curry JL; Ning J; Piao J; Torres-Cabala CA; Aung PP; Ivan D; Ross MI; Levenback CF; Frumovitz M; Gershenwald JE; Davies MA; Malpica A; Prieto VG; Tetzlaff MT
Clin Cancer Res; 2017 Apr; 23(8):2093-2104. PubMed ID: 27864417
[No Abstract] [Full Text] [Related]
19. Prognosis and Management of Thick and Ultrathick Melanoma.
Blakely AM; Cohen JT; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2019 Nov; 42(11):824-829. PubMed ID: 31517636
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]